Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of chronic heart failure: a review of recent drug trials.

× No keyword cloud information.

38 in total

1. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.

Authors: H Ikram; D Fitzpatrick
Journal: Lancet Date: 1981-09-05 Impact factor: 79.321

2. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

Authors: C V Leier; P Huss; R D Magorien; D V Unverferth
Journal: Circulation Date: 1983-04 Impact factor: 29.690

3. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.

Authors: B L Kramer; B M Massie; N Topic
Journal: Circulation Date: 1983-04 Impact factor: 29.690

4. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.

Authors: M B Higginbotham; K G Morris; D A Bramlet; R E Coleman; F R Cobb
Journal: Am J Cardiol Date: 1983-10-01 Impact factor: 2.778

5. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.

Authors: K T Weber; V Andrews; J S Janicki; M Likoff; N Reichek
Journal: Circulation Date: 1982-12 Impact factor: 29.690

6. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

Authors: D R Glover; C G Wathen; R G Murray; M C Petch; A L Muir; W A Littler
Journal: Br Heart J Date: 1985-02

7. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

Authors: J L Fleg; S H Gottlieb; E G Lakatta
Journal: Am J Med Date: 1982-08 Impact factor: 4.965

8. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.

Authors: J A Franciosa; K T Weber; T B Levine; G T Kinasewitz; J S Janicki; J West; M M Henis; J N Cohn
Journal: Am Heart J Date: 1982-09 Impact factor: 4.749

9. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.

Authors: R V Markham; J R Corbett; A Gilmore; W A Pettinger; B G Firth
Journal: Am J Cardiol Date: 1983-05-01 Impact factor: 2.778

9. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.

Authors: M G Collis; J R Keddie; W Rouse
Journal: Br J Pharmacol Date: 1989-06 Impact factor: 8.739

Review 10. Effect of drug treatment on quality of life in mild to moderate heart failure.

Authors: D G Waller
Journal: Drug Saf Date: 1991 Jul-Aug Impact factor: 5.606

Treatment of chronic heart failure: a review of recent drug trials.

1. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.

2. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.

3. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.

4. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise.

5. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.

6. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo.

7. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

8. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.

9. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.

10. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.

Review 1. Drugs, heart failure and quality of life: what are we achieving? What should we be trying to achieve?

Review 2. Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Review 3. Quality of life as an outcome measure.

4. Symptoms limiting exercise in chronic heart failure.

5. Measurement of the quality of life in congestive heart failure-Influence of drug therapy.

6. Angiotensin-converting-enzyme inhibitors in hemodynamic congestion: a meta-analysis of early studies.

7. Digoxin revived?

8. Delayed improvement in exercise capacity after cardioversion of atrial fibrillation to sinus rhythm.

9. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.

Review 10. Effect of drug treatment on quality of life in mild to moderate heart failure.